Endovascular embolisation strategies for pulmonary arteriovenous malformations
More details
Hide details
Submission date: 2018-02-06
Final revision date: 2018-02-22
Acceptance date: 2018-02-23
Publication date: 2018-05-09
Pol J Radiol, 2018; 83: 189-196
To assess the immediate efficacy of distinct embolisation devices in the endovascular treatment of pulmonary arteriovenous malformations as well as to identify and analyse the possible determinants of the technical success of the procedure.

Material and methods:
Prospective analysis of 16 consecutive patients was carried out, who underwent transcatheter endovascular embolisation therapy for pulmonary arteriovenous malformations between 2005 and 2017. Pre- and post-procedural angiography studies were implemented to confirm the diagnosis and to evaluate the technical success defined as the complete occlusion of the feeding artery. Embolisation devices – coils, microcoils, occluders, or combination of the above – were used. All the patients were advised to conduct a follow-up computed tomography evaluation 12 months after the procedure.

A total of 40 pulmonary arteriovenous malformations (PAVMs) were observed and embolised. The immediate technical success was achieved in all (n = 40; 100%) treated PAVMs, as confirmed by the post-procedural angiographic result. The statistical analysis revealed no significant impact of the number of PAVMs per patient (p > 0.05), their angioarchitecture (p > 0.05), localisation within the lung (p > 0.05) or particular lobe (p > 0.05), and the selection of embolisation device (p > 0.05) on the procedural success rates. The procedure-related complication rate was equal to 6.25%.

The immediate success rate of the transcatheter PAVM embolisation reached 100% in this study. The statistical model of logistic regression revealed no significant impact of the number of PAVMs per patient, their angioarchitecture, localisation, and distribution pattern, as well as device selection, on the immediate technical success of the procedure.

Hsu CC, Kwan GN, Evans-Barns H et al. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev 2018; 1: CD008017.
White RI Jr, Lynch-Nyhan A, Terry P et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169: 663-669.
Giordano P, Nigro A, Lenato GM et al. Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician. J Thromb Haemost 2006; 4: 1237-1245.
Brinjikji W, Nasr DM, Wood CP et al. Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients. Cerebrovasc Dis 2017; 44: 179-185.
Pollak JS, Saluja S, Thabet A et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17: 35-44.
Shovlin CL, Jackson JE, Bamford KB et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63: 259-266.
Pierucci P, Murphy J, Henderson KJ et al. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest 2008; 133: 653-661.
Faughnan ME, Palda VA, Garcia-Tsao G et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48: 73-87.
Gossage Jr, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158: 643-661.
Mager JJ, Overtoom TT, Blauw H et al. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004; 15: 451-456.
White RI Jr. Pulmonary arteriovenous malformations: how do I embolize? Tech Vasc Interv Radiol 2007; 10: 283-290.
Hundt W, Kalinowski M, Kiessling A et al. Novel approach to complex pulmonary arteriovenous malformation embolization using detachable coils and Amplatzer vascular plugs. Eur J Radiol 2012; 81: 732-738.
Remy-Jardin M, Dumont P, Brillet PY et al. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. Radiology 2006; 239: 576-585.
Pollak JS, White RI Jr. Distal cross-sectional occlusion is the “key” to treating pulmonary arteriovenous malformations. J Vasc Interv Radiol 2012; 23: 1578-1580.
Rabellino M, Serra M, Peralta O et al. Early experience with the AMPLATZER vascular plug IV for the occlusion of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2014; 25: 1333-1337.
Abdel Aal AK, Eason J, Moawad S. Persistent Pulmonary Arteriovenous Malformations: Percutaneous Embolotherapy. Curr Probl Diagn Radiol 2017; https://doi.org/10.1067/j.cpra....
Tau N, Atar E, Mei-Zahav M. Amplatzer Vascular Plugs Versus Coils for Embolization of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia. Cardiovasc Intervent Radiol 2016; 39: 1110-1114.
Borrero CG, Zajko AB. Pulmonary arteriovenous malformations: clinical features, diagnosis, and treatment. J Radiol Nurs 2006; 25: 33-37.
White RI Jr, Pollak JS, Picus D. Are Guglielmi detachable coils necessary for treating pulmonary arteriovenous malformations? Radiology 2003; 226: 599-600.
NCT01856842. Reperfusion of pulmonary arteriovenous malformations after embolotherapy. A randomized trial of Interlock™ Fibered IDC™ Occlusion System vs. Nester Coils. Available at: https://clinicaltrials.gov/ct2... (Accessed: 04 February 2018).
Martin JL, Faughnan ME, Prabhudesai V. Antithrombotic Use Predicts Recanalization of Embolized Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Can Assoc Radiol J 2017; 68: 463-467.
Journals System - logo
Scroll to top